芝浦工業大学（東京都港区／学長 山田純）工学部機械工学科・二井信行教授ら研究チームは、ヒト血漿から無細胞DNA（cfDNA）を効率的に抽出・精製する開放型マイクロ流体装置を開発しました。 がんなどの治療を行う際に、事前検査として病変組織を採取し ...

Divya Gupta, MD, assistant professor at Feinberg School of Medicine at Northwestern University, discussed the potential of using circulating tumor DNA and minimal residual disease (MRD) assays for ...

A DNA nano-harvester stays on its track inside tumor cells, measuring cancer aggressiveness by detecting a key microRNA ...

相同組換えは、DNA分子間の遺伝情報の交換を可能にするDNA修復機構だ。RecAというタンパク質がその過程を取り仕切る様子が、構造解析で明らかにされた。 我々生物の染色体は、常に、ゲノムの完全性が損なわれかねないようなDNA損傷を与える、紫外線や ...

NEW YORK and PARIS, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Rarecells, a pioneer in liquid biopsy technologies, today presented new data (poster EP.06.64) at the IASLC 2025 World Conference on Lung Cancer ...

Please provide your email address to receive an email when new articles are posted on . Approximately 25% of patients had ctDNA- or imaging-confirmed recurrence. More than 30% had evidence of ...

JSTのERATO審良自然免疫プロジェクトとして、審良 静男（大阪大学免疫学フロンティア研究センター拠点長）、石井 健（同微生物病研究所難治感染症対策研究センター准教授）らは、「DNAワクチン」とよばれる新型ワクチンの作用メカニズムを ...

Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Newborn Screening Market Size, Share & Trends Analysis Report by Product (Instruments and Reagents & Assay Kits), Technology (Tandem Mass Spectrometry, ...

Researchers at the Icahn School of Medicine at Mount Sinai have reported promising findings that may help redefine treatment for patients with muscle-invasive bladder cancer, a potentially aggressive ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...